ICH E6 (R2) reached Step 4 (finalization) in November 2016. So, now this revision to GCP is in Step 5 (Implementation). When will FDA and EMA require clinical trials to adhere to the revision?
Kind regards,
Dawn
---
Dawn M. Edgerton, MBA, RAC
Owner
http://www.edgerton-data.com
(919) 270-3100
Regulatory Affairs Professionals Society (RAPS)5635 Fishers Lane, Suite 400Rockville, Maryland 20852
raps@raps.org+1 301 770 2920
JoinMy RAPS DashboardLearn More
About UsTerms of UsePrivacy Policy